Navigation Links
Stem Cell Transplants Ease Parkinson's Symptoms in Monkeys

Scientists have successfully eased the symptoms of Parkinson's disease in monkeys with the help of human stem cell transplants .

During the course of study, published in the Proceedings of the National Academy of Sciences, the scientists isolated stem cells from the brains of aborted foetuses, and grew them into large numbers in the laboratory.

Thereafter, they injected the cells into the brains of monkeys with a severe form of chemically induced Parkinson's disease.

Before the treatment, the monkeys could not walk unaided, struggled to use their hands, and sometimes were unable to move at all. However two months after the treatment, they started walking, feeding themselves, and move more normally.

"They're not as good as normal monkeys, but the improvement is still dramatic," Nature magazine quoted team-member and neuroscientist Richard Sidman from the Harvard Institutes of Medicine, Boston, Massachusetts, as saying.

The study shows that that stem cells not only replace cells, but also persuade the brain to heal itself.

"People used to think that stem cells transplants would work by replacing missing cells. But these results suggest they may do more than that. They may actually switch on the brain's own innate repair mechanisms," says neuroscientist John Sinden from the UK stem-cell company ReNeuron.

Evan Snyder from the California based Burnham Institute for Medical Research says that much more basic research needs to be conducted before clinical trials are carried out.

"It's becoming clear that transplanted neural stem cells exert their behavioural effects through a series of mechanisms," he says.

"There's a whole network of activity and crosstalk," he adds.


'"/>




Page: 1

Related medicine news :

1. Stem Cell Transplants May Be Effective For MS Patients
2. Kidney Failure after Non-Kidney Transplants
3. Transplants Help Liver Cancer Patients
4. Steroid-Free Liver Transplants
5. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
6. Rejection Rate for Liver Transplants Patient Reduced
7. The Use Of Steroids After Liver Transplants Questioned
8. Strategies To Boost Living Donor Kidney Transplants
9. Face Transplants To Commence In The UK
10. Double Kidney Transplants to Solve Organ Donor Shortage
11. Neurological Damage Can Be Reduced By Stem Cell Transplants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... , ... In the United States, 20 million women and 10 million men ... feel shame for having struggled with an eating disorder as well as common co-occurring ... in Life After an Eating Disorder” -- to be featured at this year’s iaedp ...
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
(Date:1/20/2017)... ... , ... Doctor C LLC, a company based out of Arizona that focuses ... the marketing and distribution of its product, The Right C. , The Right C ... than traditional vitamin C supplements. At the trade show, Doctor C had the opportunity ...
(Date:1/20/2017)... ... 20, 2017 , ... ATP Science, an Australian-based company focused ... the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding meetings ... of supplements that keep the body functioning at its peak performance by providing ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ( ... treat mitochondrial dysfunction, today announced new additions to its ... as Chief Medical Officer, and Daniel Geffken ... that Jim Carr , Pharm.D. has been promoted ... are pleased to welcome Doug and Daniel to our ...
(Date:1/19/2017)... 19, 2017 James ... & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European ... touchONCOLOGY, an article by James Gilbart ...
(Date:1/19/2017)... , January 19, 2017 ... Otsuka in the Milner Therapeutics Consortium   ... in Cambridge   ... PFE ) as a partner to the ... Consortium, which enables the efficient transfer of materials between ...
Breaking Medicine Technology: